PT003 MDI Dose Confirmation Study

PHASE2CompletedINTERVENTIONAL
Enrollment

185

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

PT003

PT003 MDI administered as two puffs BID for 7 days

DRUG

PT001

PT001 MDI administered as two puffs BID for 7 days

DRUG

PT005

PT005 MDI administered as two puffs BID for 7 days

Trial Locations (13)

Unknown

Pearl Investigative Site, Rancho Mirage

Pearl Investigative Site, Colorado Springs

Pearl Investigative Site, Waterbury

Pearl Investigative Site, Clearwater

Pearl Investigative Site, Pensacola

Pearl Investigative Site, Stockbridge

Pearl Investigative Site, Minneapolis

Pearl Investigative Site, Brooklyn

Pearl Investigative Site, Charlotte

Pearl Investigative Site, Winston-Salem

Pearl Investigative Site, Cincinnati

Pearl Investigative Site, Medford

Pearl Investigative Site, Spartanburg

Sponsors
All Listed Sponsors
lead

Pearl Therapeutics, Inc.

INDUSTRY